Vaccitech (VACC) Competitor Comparison
We are evaluating the key criteria listed to compare Vaccitech (VACC) against its competitors in the Biotechnology industry.
Market Capitalization
232 / 368Gross Profits
0 / 278Total Revenue
176 / 300EBITDA
155 / 337Free Cashflow
118 / 352Quick Ratio
44 / 357Earnings per Share
168 / 359Dividend yield
0 / 6Total Cash
173 / 358Performance 3 years
236 / 368Performance 5 years
222 / 368Performance 10 years
191 / 368Linearity 3 years
182 / 368Linearity 5 years
206 / 368Linearity 10 years
171 / 367Total Rank
51 / 368Dividend Rank
297 / 368Valuation Rank
158 / 368Piotroski Rank
118 / 368Muliplier Rank
122 / 368Market Capitalization - VACC ranking 232 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.